Chroma to Present Phase I Efficacy Data for Novel Cancer Therap... ( OXFORD England Nov. 30 /- Chroma ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Chroma to Present Phase I Efficacy Data for Novel Cancer Therapy CHR-2797

Date:11/30/2007

OXFORD, England, Nov. 30 /PRNewswire/ -- Chroma Therapeutics Limited announced today that it will report efficacy data from a Phase I clinical trial of its oral, once-daily experimental cancer therapy CHR-2797 at the forthcoming American Society of Hematology (ASH) meeting. CHR-2797 is the only oral aminopeptidase inhibitor currently in clinical development. The company will also be presenting the results of various preclinical studies. Details of the presentations are as follows:

Abstract # 443: oral presentation

Title: A Phase I Study of CHR-2797, an Orally Active Aminopeptidase

Inhibitor in Elderly and/or Treatment Refractory Patients with Acute

Myeloid Leukemia

Location and timing: Acute Myeloid Leukemias: Therapy, excluding

Transplantation-Novel Therapies, Rooms A411-A412: Monday December 10,

2007, 13:30-15:00 Eastern Standard Time

Presenter: Dr Faith Davies (Royal Marsden Hospital, London, UK)

Abstract # 1608, Poster # 762

Title: Cellular Aminopeptidase Inhibition as a Target for the Therapy of

AML by the Novel Agent CHR-2797

Location and timing: Poster Session I, Hall B4: Saturday, December 8,

2007, 17:30-19:30 Eastern Standard Time

Presenter: Dr Chris Jenkins (University Hospital, Cardiff, UK)

Abstract # 2505, Poster # 695

Title: Aminopeptidase Inhibition as a Targeted Treatment Strategy in

Myeloma

Location and timing: Poster Session II, Hall B4: Sunday, December 9,

2007, 18:00-20:00, Eastern Standard Time

Presenter: Dr Faith Davies (Royal Marsden Hospital, London, UK)

The ASH posters will be available at the company's website, http://www.chromatherapeutics.com following the above presentations.

Enquiries

Chroma Therapeutics Limited

Ian Nicholson Chief Executive Officer +44 (0)1235 829120'/>"/>

SOURCE Chroma Therapeutics Limited
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Chromatin remodeling complex connected to DNA damage control
2. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
3. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
4. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
5. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
7. AtriCure to Present at Roth Capital Partners 2007 New York Conference
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. MDS to Present at Thomas Weisel Partners Healthcare Conference
10. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
11. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007

Post Your Comments:

(Date:6/19/2013)... NC (PRWEB) June 19, 2013 ... Inc., announced organizational changes to advance development of ... Mowell said, “To support the advanced development of ... made changes to the Company’s management structure and ... , The Company announced that Michael Galiger will ...

(Date:6/19/2013)... Brightree LLC , the leading provider of ... post-acute care industry, has been ranked for the first time ... 100 (HCI 100) list. This prestigious list features the ... of revenue during the last fiscal year. Since 2005, Brightree’s ... and the company has built its organization to more than ...

(Date:6/19/2013)... Many trying-to-conceive couples seek medical intervention ... to a recent study published in ... of this research confirm what Fairhaven Health has ... that trying-to-conceive women would benefit from tracking ovulation, ... Fairhaven Health is a leading provider of ovulation ...

(Date:6/19/2013)... vaccination, polio has been pushed to the brink of extinction ... one of the big questions which a Bristol academic addresses ... Williams, Professor of Medicine at the University of Bristol, has ... years. Paralysed with fear: the story of polio explores the ... the history of the disease. , According to ...

(Date:6/19/2013)... Boston, MA (PRWEB) June 19, 2013 ... Productions , a premier kids entertainment media organization, ... Massachusetts-based serious games company, will be introducing the ... game, StudenTopia. The 3D game is geared toward ... healthy eating and active lifestyles by rewarding positive ...

Breaking Medicine News(10 mins):Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 2 Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 3 Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2 Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3 Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2 Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3 Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4 Health News:Paralysed with fear: The story of polio 2 Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 2 Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 3 Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 4 Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 5

[0] Entegrion Announces Organizational Changes to Support Advanced Product Development [0] Brightree Debuts on List of Top 100 Healthcare Technology Companies [0] Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies [0] Paralysed with fear: The story of polio [0] Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference

... Geographic Strength to Achieve Top Five Global Market ... ... 1, 2008 Underwriters,Laboratories (UL), a world leader of product safety ... DQS, a leading global registrar in independent third party management,system certification ...

... Do humans hear better than animals? It is ... creatures are capable of hearing some lower and higher ... from the Hebrew University of Jerusalem and elsewhere have ... of single neurons give humans the capability of detecting ...

... Way to Rehabilitate Stroke Patients, DALLAS, April 1, ... a stroke each year, many never regain the,ability to ... physical,therapists, using a specialized treadmill, have discovered a new ... The results of their study, conducted at Baylor Institute ...

... April 1, 2008 Global,marketing information firm J.D. ... Companies, celebrates its 40th anniversary today, marking,four decades ... "Dave" Power III,of integrating the voice of the ... satisfaction., (Logo: http://www.newscom.com/cgi-bin/prnh/20050527/LAF028LOGO-a ), In ...

... is obstructing good patient care , , MONDAY, March 31 ... support the concept of national health insurance, which represents ... a new survey finds. , Typically, national health ... fund that guarantees health coverage for everyone. In most ...

... Line for Women With Melanin-Rich Skin Tones, SKILLMAN, N.J., ... women with melanin-rich skin tones between,the ages of 25 and ... is not the only skin concern for these women. Women ... skin soft,and even-toned due to the excess melanin in their ...

Cached Medicine News:Health News:Underwriters Laboratories' Management System Registration Business to Merge With Germany's DQS 2 Health News:Humans have more distinctive hearing than animals, Hebrew U study shows 2 Health News:Stroke Patients Re-Learn to Walk Correctly Again Using Special Treadmill 2 Health News:J.D. Power and Associates Celebrates 40th Anniversary of Representing the Voice of the Customer 2 Health News:J.D. Power and Associates Celebrates 40th Anniversary of Representing the Voice of the Customer 3 Health News:J.D. Power and Associates Celebrates 40th Anniversary of Representing the Voice of the Customer 4 Health News:J.D. Power and Associates Celebrates 40th Anniversary of Representing the Voice of the Customer 5 Health News:Majority of U.S. Doctors Back National Insurance Plan 2 Health News:AMBI(R) Introduces SOFT & EVEN(TM) 2 Health News:AMBI(R) Introduces SOFT & EVEN(TM) 3

Underwriters Laboratories' Management System Registration Business to Merge With Germany's DQS Humans have more distinctive hearing than animals, Hebrew U study shows Stroke Patients Re-Learn to Walk Correctly Again Using Special Treadmill J.D. Power and Associates Celebrates 40th Anniversary of Representing the Voice of the Customer Majority of U.S. Doctors Back National Insurance Plan AMBI(R) Introduces SOFT & EVEN(TM)

(Date:6/19/2013)... Pharma IQ is pleased to announce ... of the results from an industry survey conducted earlier this ... that CROs would be an area of active investment in ... 6 or more clinical trials in the BRIC region. The ... USA Summit explores the latest trends, challenges ...

(Date:6/18/2013)... 2013 Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT ... development and commercialization of novel bile acid therapeutics to ... an underwritten public offering of 1,730,000 shares of its ... per share. In addition, Intercept has granted the underwriters ... 259,500 shares of common stock. All of ...

(Date:6/18/2013)... Royal Philips (NYSE: PHG, AEX: ... Leader in Imaging Equipment in the 2013 Best in ... received Best in KLAS and Best in Category awards ... Computed Tomography (CT), Ingenia 1.5T and 3.0T Magnetic ... annual Best in KLAS Awards: Medical Imaging & Infrastructure ...

Breaking Medicine Technology:Pharma IQ Presents the Latest Trends in Clinical Trial Supply 2 Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2 Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS 2

[0] Pharma IQ Presents the Latest Trends in Clinical Trial Supply [0] Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock [0] Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS

... LAS VEGAS, Dec. 14, 2011 American Pacific Corporation (NASDAQ: ... 2011 year and fourth quarter ended September 30, 2011. ... financial results based on GAAP. A reconciliation of the non-GAAP ... in this release and the accompanying supplemental data. ...

... To help reduce state Medicaid spending, the Obama administration ... into private health plans by 2013. Despite strong opposition ... to modernize the state,s prescription drug benefits to be ... Medicare and the private sector. Currently the Texas Medicaid ...

American Pacific Reports Fiscal 2011 Results Texas to Modernize Medicaid Rx Benefits, Curb Pharmacy Overpayments

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

Medicine Products:

Pentachlor Penta Pemphigoid, Tissue Pemphigoid Panel-Epithelial Basement Membrane Zone IgG & IgA, BP180 & BP230 IgG Antibodies